Circassia appoints Brett Haumann CMO
This article was originally published in Scrip
Executive Summary
Circassia, which is focused on allergy, has appointed Dr Brett Haumann chief medical officer. Dr Haumann joins Circassia from GlaxoSmithKline where he was vice-president and medicines development leader responsible for the late-stage development of once-daily inhaled medicines for the treatment of asthma and COPD.